Pure Global

Safety and Efficacy of the Bi-Aspheric Monofocal IOL - Trial NCT06380478

Access comprehensive clinical trial information for NCT06380478 through Pure Global AI's free database. This phase not specified trial is sponsored by ICARES Medicus, Inc. and is currently Recruiting. The study focuses on Cataract. Target enrollment is 30 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.

Free Database
Powered by Pure Global AI
840K+ Trials
Device Trial
NCT06380478
Recruiting
Device Trial
device
Trial Details
ClinicalTrials.gov โ€ข NCT06380478
View on ClinicalTrials.gov
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Safety and Efficacy of the Bi-Aspheric Monofocal IOL
Safety and Efficacy of the Bi-Aspheric Monofocal Intraocular Lens

Study Focus

Cataract

aspicio Monofocal IOL

Observational

device

Sponsor & Location

ICARES Medicus, Inc.

Taoyuan, Taiwan

Timeline & Enrollment

N/A

Mar 05, 2024

Dec 25, 2024

30 participants

Primary Outcome

CDVA,Defocus curve

Summary

This is an observational, single-center, non-control, open-label post-marketing study.
 Patients implanted with an aspicioโ„ข Monofocal Intraocular Lens will be scheduled for a
 follow-up visit at least 3 months after the surgery to undergo a routine basic
 ophthalmological examination.

ICD-10 Classifications

Other cataract
Cataract, unspecified
Complicated cataract
Other specified cataract
Senile cataract

Data Source

ClinicalTrials.gov

NCT06380478

Device Trial